HORMAD1 Polymorphisms Influence Susceptibility to Esophageal Squamous Cell Carcinoma Through Gene–Smoking Interaction
Molecular Carcinogenesis · 2025
DOI: 10.1002/mc.70039 ↗At a glance
Journal article in Molecular Carcinogenesis, 2025. Written by Xinying Yue and 9 co-authors. Institution: Department of Health Toxicology, Key Laboratory for Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of S…. Major MEDLINE topics: Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Genetic Predisposition to Disease, Smoking. 69 references. Funded by: This study was supported by the Grants 2020CFA067 and 2021YFC2502000..
Abstract (original language)
Tobacco smoke is a major risk factor for esophageal squamous cell carcinoma (ESCC), yet only a subset of smokers develop this disease, implicating gene–smoking interactions in modulating individual susceptibility. Through integrative transcriptomic analyses of normal and tumor samples from smokers and nonsmokers, we identify four smoke‐responsive genes ( CXCL14, HORMAD1, WFDC5 , and MPZ ) as potential contributors to ESCC carcinogenesis. Among these, HORMAD1 is markedly upregulated in ESCC cells upon exposure to cigarette smoke condensate (10 µg/mL), benzo[a]pyrene (3 µM), or 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone (10 µM), correlating with activation of error‐prone nonhomologous end joining (NHEJ) in response to DNA damage. Notably, smokers with higher HORMAD1 expression levels exhibit enhanced NHEJ but impaired homologous recombination (HR), leading to increased genomic instability. Through a two‐stage case–control study involving 5151 ESCC cases and 5963 controls, we identify two regulatory variants of HORMAD1 , rs11204679 and rs33924488, significantly associated with ESCC risk through a gene–smoking interaction ( p interaction = 0.0027). Both variants confer a protective effect among smokers (OR = 0.80, 95% CI: 0.74–0.87, p = 9.58 × 10 − 8 ) but not in nonsmokers (OR = 0.98, 95% CI: 0.90–1.06, p = 0.5950). Mechanistically, the rs11204679 G > C and rs33924488 GA > G− variants attenuate HOXA6 and SOX15 binding at a distal enhancer, respectively, suppressing HORMAD1 expression via long‐range chromatin interactions. These findings establish HORMAD1 as a critical mediator of tobacco‐related DNA repair dysregulation and a potential biomarker for ESCC risk stratification and precision prevention.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Health Toxicology, Key Laboratory for Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
ORCID profiles: Jiang Chang
Funding
- This study was supported by the Grants 2020CFA067 and 2021YFC2502000.
Cite
APA
Yue, X., Yang, Z., Ma, J., Su, Q., Pan, M., Song, L., Li, Y., Liu, S., Wu, Y., & Chang, J. (2025). HORMAD1 Polymorphisms Influence Susceptibility to Esophageal Squamous Cell Carcinoma Through Gene–Smoking Interaction. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70039
Vancouver
Yue X, Yang Z, Ma J, Su Q, Pan M, Song L, et al. HORMAD1 Polymorphisms Influence Susceptibility to Esophageal Squamous Cell Carcinoma Through Gene–Smoking Interaction. Molecular Carcinogenesis. 2025. doi:10.1002/mc.70039
BibTeX
@article{Yue2025,
author = {Yue, Xinying and Yang, Zifei and Ma, Jialing and Su, Qianqian and Pan, Miaoxin and Song, Lina and Li, Yueping and Liu, Shasha and Wu, Yutong and Chang, Jiang},
title = {HORMAD1 Polymorphisms Influence Susceptibility to Esophageal Squamous Cell Carcinoma Through Gene–Smoking Interaction},
journal = {Molecular Carcinogenesis},
year = {2025},
doi = {10.1002/mc.70039}
}
EUVIMED